Join us for an upcoming Outsourced Pharma Capabilities Update, where Detra Glinatsis, our Head of Business Development, U.S., will share how Rentschler Biopharma helps biopharma innovators de-risk complex biologics programs and build a reliable path from development to commercialization.
With more than 50 years of proven biologics expertise, flexible cGMP manufacturing, and strengthened U.S.-based clinical and commercial capabilities at our site in Milford, MA, we deliver high-impact technical expertise, partnerships rooted in trust, and tailored solutions that help move your program forward.
If you are planning, scaling, or preparing your next large molecule program, this session is for you.
Register by clicking the link below today to secure your spot.
Date: July 29
Time: 1:00 p.m. EST
Registration: https://lnkd.in/efNSfZ3E
RentschlerBiopharma CDMO ReliabilityYouCanTrust OutsourcedPharmaCapabilitiesUpdate Milford
RENTSCHLER BIOPHARMA – Outsourced Pharma Capabilities Update: Large Molecule/Our Site in Milford, MA
Jul 28, 2026
Our strengthened U.S.-based clinical and commercial capabilities in Milford support programs as they scale
Posted by Rentschler Biopharma Inc